NuFACE Against ZIIP Halo, an Outside Comparison

Medically reviewed by

4 independent reviewers

Andrew Conrad Barile, Physiotherapeut, Doktor der Physiotherapie

Andrew Conrad Barile, Physiotherapeut, Doktor der Physiotherapie

Doktor der Physiotherapie (DPT), Lizenzierter Physiotherapeut (PT)

Read bio

Dr. Andrew Conrad Barile ist Doktor der Physiotherapie sowie CEO und Gründer von Xtreem Pulse LLC. Er erwarb seinen Doktortitel in Physiotherapie am Daemen College und bringt über zwei Jahrzehnte klinische und unternehmerische Erfahrung in der pädiatrischen Physiotherapie, Craniosacraltherapie und medizinischen Geräteinnovation mit. Sein tiefes Verständnis der menschlichen Anatomie, Muskelphysiologie und therapeutischen Technologie bietet einen wissenschaftlich fundierten Ansatz für Gesichtsverjüngung und Anti-Aging-Lösungen.

Bertica M. Rubio, M.D.

Bertica M. Rubio, M.D.

Medizinischer Direktor, Anti-Aging-Regenerationsmedizinische Klinik | Facharzt | Dartmouth Medical School

Read bio

Dr. Bertica M. Rubio ist eine zertifizierte Ärztin und medizinische Leiterin der Anti-Aging-Regenerationsklinik in Redlands, Kalifornien. Sie erwarb ihren Bachelor of Science an der Loyola Marymount University und ihren Doktortitel in Medizin an der Dartmouth Medical School (Geisel School of Medicine). Ihre Facharztausbildung in Pädiatrie absolvierte sie am UC Irvine Medical Center.

Mit jahrzehntelanger klinischer Erfahrung spezialisiert sich Dr. Rubio auf Altersmanagement, regenerative Medizin, Wundheilung und Wachstumsfaktor-Therapien. Ihre Praxis verbindet evidenzbasierte medizinische Wissenschaft mit fortschrittlichen ästhetischen und regenerativen Behandlungen, um Patienten zu optimaler Gesundheit und jugendlicher Vitalität zu verhelfen.

Dr. Rubio ist leidenschaftlich daran interessiert, Patienten über die Wissenschaft hinter Hautpflege, Gesichtsverjüngung und nicht-invasiven Technologien wie EMS (Elektrische Muskelstimulation) zur Gesichtstonung aufzuklären. Ihre Artikel für PureLift LAB verbinden fundiertes medizinisches Wissen mit praktischen Anleitungen für echte, nachhaltige Ergebnisse.

Daniel Grinberg, MD, FACS

Daniel Grinberg, MD, FACS

Facharzt für Hals-Nasen-Ohren-Heilkunde und Kopf-Hals-Chirurgie | Fellow des American College of Surgeons | Assistenz-Professor für Klinische Medizin, Mount Sinai School of Medicine

Read bio

Daniel Grinberg, MD, FACS, ist ein von der Ärztekammer zertifizierter Hals-Nasen-Ohren-Arzt und Kopf-Hals-Chirurg bei ENT and Allergy Associates in West Nyack, NY. Er erwarb seinen medizinischen Abschluss an der Columbia University College of Physicians and Surgeons, absolvierte seine Facharztausbildung in Hals-Nasen-Ohren-Heilkunde am New York University Medical Center und ist Assistenzprofessor an der Mount Sinai School of Medicine. Er ist Fellow sowohl des American College of Surgeons als auch der American Academy of Otolaryngology.

Dr. Grinbergs Perspektive als Kopf-Hals-Chirurg bietet den Lesern von PureLift LAB eine erweiterte klinische Sichtweise — er verbindet die EMS-Anwendung zu Hause mit der zugrunde liegenden medizinischen Anatomie mit derselben wissenschaftlichen Genauigkeit, die wir auf jede Gerätespezifikation anwenden.

Prof. Dr. med. Ivo Buschmann

Prof. Dr. med. Ivo Buschmann

Lehrstuhl für Angiologie, Medizinische Hochschule Brandenburg | Klinikdirektor, Universitätsklinik für Angiologie, Brandenburgisches Klinikum | Ehemaliger Oberarzt, Charité Universitätsmedizin Berlin

Read bio

Prof. Dr. med. Ivo Buschmann ist Lehrstuhlinhaber für Angiologie an der Medizinischen Hochschule Brandenburg Theodor Fontane (MHB) und Klinikdirektor der Universitätsklinik für Angiologie am Brandenburgischen Universitätsklinikum. Er absolvierte seine medizinische Ausbildung an der Universität Hamburg, war Max-Planck-Gesellschaft-Stipendiat am Max-Planck-Institut für Herz- und Lungenforschung und hatte leitende Oberarztpositionen an der Charité Universitätsmedizin Berlin Campus Virchow inne, bevor er 2016 zum Lehrstuhlinhaber an der MHB berufen wurde.

Prof. Buschmann ist einer der führenden europäischen Experten für Arteriogenese – das durch Fluss angetriebene Wachstum und die Umgestaltung von Blutgefäßen – mit mehr als 150 begutachteten Veröffentlichungen und mehreren US- und EU-Patenten für Geräte, die das Wachstum von Kollateralgefäßen durch kontrollierte Scherkräfte-Therapie stimulieren. Seine Forschung verbindet mechanische und elektrische Stimulation mit vaskulärer Anpassung, Mikrozirkulation und Gewebeperfusion.

Die Beiträge von Prof. Buschmann bieten den Lesern von PureLift LAB eine gefäßbiologische Perspektive, die unsere bestehenden Autoren aus den Bereichen Klinik, Physiotherapie und chirurgische Anatomie ergänzt – und erklären, wie EMS-Stimulation nicht nur die Gesichtsmuskeln, sondern auch die Mikrozirkulation, die sie versorgt, aktiviert und warum eine intelligente Anwendung auf der Ebene des Blutflusses ebenso wichtig ist wie die Muskelkontraktion.

What's This About:

NuFACE is the simpler device with the deeper clearance history, ZIIP is the app-led one with the broader treatment library, and their published outputs are close enough to be functionally equivalent.

This article compares the two on what decides the result you actually see, such as:

- what each brand actually publishes about output

- the gel cost underneath both devices

- how much of ZIIP depends on the app

- which clearances cover which model

- who each device genuinely suits

and many more!

We make a competing device and are not in this comparison, which is the point of it.

Key Points:

NuFACE files 335 microamps with the FDA for the MINI+, with no load stated; ZIIP publishes 309 microamps for the Halo.

Both figures sit in the same band, below the level at which a facial muscle contracts.

NuFACE gel runs $35 to $80 a bottle and its FDA file lists a conductive gel primer as a special requirement; ZIIP gels run $29.99 to $79.99.

ZIIP is app-dependent by design, with treatments delivered through the phone; NuFACE works without one.

NuFACE Trinity+ is $395, ZIIP Halo is $399.99, and the MINI+ at $175 to $250 is the cheapest way into either brand.

Why we are writing this

We sell a facial device and we are not one of the two in this comparison, which is unusual enough to be worth stating at the top.

Both of these brands have more search presence than we do, both are frequently shortlisted against each other, and the only people writing the comparison at the moment are the two companies involved.

So the figures below are taken from each brand's own material and from their FDA filings, and where a brand does not publish something, we say so rather than filling the gap.

Our own devices appear once, at the end, and you can skip that part without losing the comparison.

What each one publishes

NuFACE does not publish an output figure on its product pages. The number appears in its FDA submission for the MINI+, which gives a maximum of 335 microamps and a range from 70 to 335, with a modulated square biphasic waveform and a default treatment frequency around 8.3 Hz. No load is stated anywhere, which limits how far the figure can be compared.

ZIIP publishes 309 microamps for the Halo, which is unusual in this category and worth crediting, though it also arrives without a stated load.

The two figures are close, and both sit in the microcurrent band. Ward and colleagues described the thresholds separating sub-sensory, sensory and motor current, and neither of these devices approaches the third.

So anyone choosing between them on strength is choosing between 309 and 335 microamps, a difference you are unlikely to perceive and which neither company has characterised at a stated resistance.

The app question

ZIIP is built around its application. Treatments are selected in the phone and pushed to the device, and the library of guided treatments is the core of what the brand sells.

For some people that is the entire appeal, since it removes the guesswork about where to move the probe and for how long. For others it is friction: a download, an account, updates, and a phone that has to be charged and nearby.

NuFACE has an app as well, and the device works without it, which is a meaningful difference in day-to-day use.

Neither approach is wrong. If you already know you will not open an app four times a week, that is a decision made for you.

Running costs

NuFACE's FDA file for the MINI+ lists a conductive gel primer under special requirements, and the gel holds its own clearance, so the pairing is designed in rather than suggested. Aqua Gel Activator runs $35 for 1.69 oz, $55 for 3.3 oz and $80 for 10 oz.

ZIIP's gels run from $29.99 to $79.99 depending on formula.

Neither brand publishes how many sessions a bottle delivers, so no honest cost-per-session figure exists for either, and anyone quoting one is guessing.

On a two-year view, both devices carry a few hundred dollars of conductor behind the sticker price, which we have set out across the whole category in what every branded gel costs.

Clearances and models

NuFACE has the deeper regulatory history, with records including K201680 for the MINI+, K191672 for the earlier Mini, and K201782 and K212947 associated with the Trinity line, plus K161654 covering the gel itself.

ZIIP's Halo is associated with K212342.

Both sit under the product code covering transcutaneous electrical stimulators for aesthetic purposes, and in both cases the cleared indication is cosmetic facial stimulation rather than any biological claim. Our guide to checking any brand's clearance explains how to read those records.

On price, NuFACE MINI+ lists at $250 with a frequent $175 sale price, Trinity+ is $395, and ZIIP Halo is $399.99.

Who each one suits

Buy NuFACE if you want the simpler device, no app dependence, the option of stepping up to attachments later, and the reassurance of the longest clearance history in this category.

Buy ZIIP if the guided treatment library is genuinely what will get you to use it, and if you like the idea of different programmes for different days rather than one routine.

Buy neither if what has changed is the shape of your lower face rather than its surface, because both devices sit below the level that contracts a muscle and say so in their own materials.

That last point is where our own devices sit, and it is the only sentence in this article where we are relevant. If you want the comparison including us, it is in our NuFACE piece and our ZIIP piece.

This article sits inside our full map of the category, where we set out all 33 devices we track, what each one carries and what each brand publishes: Nine Technologies on One Dial, What the Rest of the Market Actually Carries.

Zurück zum Blog